Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Change in Receivables (2020 - 2025)

Sotera Health has reported Change in Receivables over the past 6 years, most recently at -$4.5 million for Q4 2025.

  • Quarterly results put Change in Receivables at -$4.5 million for Q4 2025, down 132.05% from a year ago — trailing twelve months through Dec 2025 was -$7.2 million (down 222.7% YoY), and the annual figure for FY2025 was -$7.2 million, down 222.7%.
  • Change in Receivables for Q4 2025 was -$4.5 million at Sotera Health, down from $6.4 million in the prior quarter.
  • Over the last five years, Change in Receivables for SHC hit a ceiling of $22.0 million in Q4 2023 and a floor of -$40.6 million in Q1 2024.
  • Median Change in Receivables over the past 5 years was $5.3 million (2024), compared with a mean of $2.0 million.
  • Biggest five-year swings in Change in Receivables: surged 854.73% in 2021 and later plummeted 296.84% in 2024.
  • Sotera Health's Change in Receivables stood at $10.6 million in 2021, then plummeted by 62.32% to $4.0 million in 2022, then skyrocketed by 451.06% to $22.0 million in 2023, then plummeted by 36.32% to $14.0 million in 2024, then crashed by 132.05% to -$4.5 million in 2025.
  • The last three reported values for Change in Receivables were -$4.5 million (Q4 2025), $6.4 million (Q3 2025), and $4.5 million (Q2 2025) per Business Quant data.